Back

Effectiveness of a bivalent RSV prefusion F protein-based vaccine in individuals with and without atherosclerotic cardiovascular disease: a prespecified analysis of the DAN-RSV trial

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Optimising cardiovascular systems: access, innovation, and socioeconomic determinants of outcomes Public Health ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Manan Pareek

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
The impact of cardiac implantable electronic devices on delays to acute magnetic resonance imaging: a two-year service evaluation
Doctor M. Dosanj (Coventry, GB)
Abstract
Presentation thumbnail
Financial strain among U.S. adults with cardiovascular conditions following reductions in food assistance benefits: a quasi-experimental policy analysis
Doctor P. Narasimmaraj (Boston, US)
Abstract
Presentation thumbnail
Cost analysis of microaxial flow pump (Impella) versus standard care in cardiogenic shock: findings from the danger shock trial
Professor B. Borregaard (Odense, DK)
Abstract
Presentation thumbnail
Building a national real-time cardiovascular quality infrastructure: five years of ESC EuroHeart implementation in Estonia
Doctor M. Serg (Tallinn, EE)
Abstract
Presentation thumbnail
Associations of socioeconomic status with length of hospital stay in a recent german myocardial infarction registry
Doctor D. Fueller (Brandenburg an der Havel, DE)
Abstract

Access the full session

Session thumbnail
Optimising cardiovascular systems: access, innovation, and socioeconomic determinants of outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Effectiveness of bivalent RSV prefusion F protein-based vaccine in individuals with and without atrial fibrillation: a prespecified analysis of the DAN-RSV trial
28 August 2026
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials
30 August 2021
thumbnail
Congress Presentation
A meta-analysis on the efficacy of influenza vaccine in reducing cardiovascular mortality and myocardial infarction in patients with cardiovascular disease
3 December 2022
thumbnail
Congress Presentation
Protective effects of COVID-19 vaccination on endothelial function of patients with COVID-19
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources